Drug Profile
V 073
Alternative Names: pocapavir; SCH-48973; V-073Latest Information Update: 25 Aug 2015
Price :
$50
*
At a glance
- Originator Schering-Plough
- Developer ViroDefense
- Class Antivirals; Small molecules
- Mechanism of Action Capsid protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Poliomyelitis
Most Recent Events
- 25 Aug 2015 No recent reports on development identified - Phase-II for Poliomyelitis in Sweden (PO)
- 19 Dec 2012 ViroDefense completes a phase II trial in Poliomyelitis in Sweden (EudraCT2011-004804-38)
- 13 Dec 2011 Phase-II clinical trials in Poliomyelitis in Sweden (PO)